...
首页> 外文期刊>Journal of Nanjing Medical University >Using dementia rating scales in the diagnosis of Alzheimer's disease
【24h】

Using dementia rating scales in the diagnosis of Alzheimer's disease

机译:使用痴呆症评定量表诊断阿尔茨海默氏病

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: To study the significance of dementia rating scales in the diagnosis of Alzheimer' s disease (AD). Methods: Probable AD patients(118 cases) diagnosed according to NINCDS-ADRDA criteria and the normal controls(100 cases) were examined with a battery of neuropsychological tests and the dementia severity of AD patients was determined with clinical dementia rating (CDR). Changed neuropsychological characteristics of different AD dementia severities were analyzed. The discriminant analysis and ROC curve analysis were performed to analyze the specificity, the sensitivity, and the general accuracy of various dementia rating scales in the diagnosis of AD, and the area under the ROC curve. Results: The total cognition function in mild (CDR=1), moderate(CDR = 2) and severe stages(CDR = 3) of AD had an obvious trend of continuous decline, with the MMSE values 17.44 ± 2.64, 13.90 ± 4.32, and 5.50 ± 3.90 respectively. The trend of decline of the verbal fluency function in AD was same as that of total cognition function. The visuo-spatial function was reduced in early stage of AD (CDR= 1) and completely lost in moderate and severe AD. Delay memory function began to show decline in the early stage of AD, and the decline turned apparent in moderate and severe AD. Immediate memory function showed unchanged in early stage of AD, while showed decline in moderate AD, and the decline became very quick in severe AD. The impairment of daily living ability and social activity function developed with the severity degree of AD. But the decline of social activity function was very quick in moderate stage of AD. In general, the leading scale to diagnose AD was FOM, followed by RVR, POD, MMSE, BD, ADL and DS. When MMSE was combined with one or more of FOM, RVR, BD, DS, the general accuracy in distinguishing AD from the normal controls was improved. Conclusion: Neuropsychological test is useful in the diagnosis of AD, especially in the early stage. The validity is improved when dementia rating scales are combined correctly.
机译:目的:研究痴呆评定量表在阿尔茨海默氏病(AD)诊断中的意义。方法:通过一系列神经心理学测试检查根据NINCDS-ADRDA标准诊断的AD患者(118例)和正常对照(100例),并通过临床痴呆评分(CDR)确定AD患者的痴呆严重程度。分析了不同AD痴呆严重程度的变化的神经心理学特征。进行判别分析和ROC曲线分析,以分析各种痴呆等级量表在AD诊断中以及ROC曲线下的面积的特异性,敏感性和一般准确性。结果:轻度(CDR = 1),中度(CDR = 2)和重度(CDR = 3)AD的总认知功能呈持续下降的明显趋势,MMSE值分别为17.44±2.64、13.90±4.32,和5.50±3.90。 AD中口语流利功能的下降趋势与总认知功能下降的趋势相同。在AD的早期阶段(CDR = 1),视觉空间功能降低,而在中度和重度AD中完全丧失。延迟记忆功能在AD的早期阶段开始显示下降,并且在中度和重度AD中下降明显。在AD的早期,立即记忆功能没有变化,而中度AD则下降,而重度AD的下降很快。日常生活能力和社交活动功能的损害随着AD的严重程度而发展。但是在AD适度阶段,社交活动功能的下降很快。通常,诊断AD的领先规模是FOM,其次是RVR,POD,MMSE,BD,ADL和DS。当MMSE与FOM,RVR,BD,DS中的一项或多项结合使用时,将AD与正常对照区分开的一般准确性得到了提高。结论:神经心理学测试可用于AD的诊断,尤其是在早期阶段。正确组合痴呆评定量表可以提高有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号